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Objectives. We sought to further elucidate the role of early
afterdepolarizations (EADs) and interventricular dispersion of
repolarization (DAPD) in the genesis of acquired torsade de
pointes (TdP) arrhythmias.
Background. Administration of class III agents can be associ-
ated with TdP. We developed a dog model in which TdP can be
reproducibly induced by pacing after d-sotalol. This model shows
reproducible results over weeks.
Methods. In 14 anesthetized dogs with chronic complete atrio-
ventricular block, two separate experiments were performed in
which d-sotalol (2 mg/kg body weight) or almokalant (0.12 mg/kg)
was administered. Monophasic action potentials were simulta-
neously recorded from the endocardium of the right and left
ventricle to register EADs and to measure the action potential
duration (APD). DAPD was defined as the APD of the left
ventricle minus that of the right ventricle.
Results. Baseline conditions were identical in the serially
performed experiments. The cycle length and QT time increased
by 16% and 26% after d-sotalol and by 15% and 31% after
almokalant, respectively. After both drugs the action potential of
the left ventricle prolonged more than that of the right ventricle,
thereby increasing DAPD (almokalant [mean 6 SD]: 110 6
60 ms; d-sotalol: 80 6 45 ms, p < 0.05). The incidence of EADs (18
of 22 vs. 11 of 24, p < 0.05) and single ectopic beats (EBs) (1.5 6
2 vs. 24 6 32, p < 0.01) was more frequently observed after
almokalant than after d-sotalol. Moreover, multiple EBs only
occurred after almokalant. These beats interfered with the basic
rhythm, leading to dynamic changes in left ventricular APD and to
additional increases in DAPD. Spontaneous TdP was observed in
9 of 14 dogs after almokalant and could be increased to 12 of 14
with programmed electrical stimulation. After d-sotalol, TdP
could only be induced by programmed electrical stimulation (5 of
14, p < 0.05).
Conclusions. In the same dog, almokalant induced more delay
in repolarization, more EADs, multiple EBs and more ventricular
inhomogeneity in APD than d-sotalol. These changes were related
to a higher incidence of TdP and thereby confirm a strong
association of the occurrence of EADs, multiple EBs and DAPD in
the genesis of TdP. These findings also show the possible value of
our model for evaluating the proarrhythmic potential of different
drugs.
(J Am Coll Cardiol 1997;30:1575–84)
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Antiarrhythmic drugs that prolong repolarization without af-
fecting conduction have attracted interest because of their
possible value in the prevention and suppression of reentrant
tachycardias (1–3). However, class III drugs do produce tor-
sade de pointes (TdP) arrhythmias in ;1% to 5% of patients
(1,2,4–9).
Many reports have pointed to the relevance of early after-
depolarizations (EADs) and EAD-dependent ectopic beats
(EBs) for the initiation of TdP arrhythmias (9–13). Whether
they are solely responsible for the initiation of TdP arrhyth-
mias or whether other factors such as ventricular dispersion of
repolarization also contribute is still a matter of discussion
(14,15). Regional differences in the duration of the action
potential can be present within the ventricular wall (transmu-
ral), within one ventricle (intraventricular) or between ventri-
cles (interventricular).
In anesthetized dogs with chronic complete atrioventricular
(AV) block, TdP could be reproducibly initiated using the
combination of d-sotalol and pacing in 50% of experiments
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(16). We compared inducible versus noninducible TdP in this
canine model and demonstrated (17) that the number of EADs
is higher and the amount of interventricular dispersion larger
than in inducible dogs. Because the response is maintained
over weeks (16), we compared the effects of two antiarrhythmic
drugs, d-sotalol and almokalant, in their ability to induce TdP
arrhythmias in the same dog. In this way we could assess
whether differences in the occurrence of EADs, EAD-
dependent EBs or interventricular dispersion or repolarization
could explain spontaneous initiation of TdP.
Methods
The study protocol was approved by the Committee for
Experiments on Animals of the University of Limburg, Maas-
tricht, The Netherlands and was conducted in accordance with
the guidelines of the American Physiological Society.
General protocol. The experiments were performed in
anesthetized adult male and female mongrel dogs with a body
weight between 20 and 31 kg. In a preliminary operation, a
right thoracotomy was performed to induce a permanent
complete AV block by injection of 37% formaldehyde into the
AV junction (18). During the same session, a pacing electrode
(Bakken Research Center, Medtronic) was inserted at the apex
of the left ventricle. The wire was exteriorized through the
back of the neck of the dog. Six surface electrocardiographic
leads and two endocardial monophasic action potential (MAP)
signals were simultaneously registered and stored on optical
disc. All drugs were administered through a cannula in the
cephalic vein.
Anesthesia was induced by 1) intramuscular premedication
(1 ml/5 kg: 10 mg of oxycodon, 1 mg of acepromazine and
0.5 mg of atropine), and 2) sodium pentobarbital (20 mg/kg
body weight intravenously). The dogs were artificially venti-
lated through a cuffed endotracheal tube using a mixture of
oxygen, nitrous oxide and halothane (vapor concentration
0.5% to 1%) by a respirator. Ventilation was controlled by
continuous reading of the carbon dioxide concentration in the
expired air. A thermal mattress was used to maintain adequate
body temperature.
Proper care was taken before and after the experiments,
including antibiotic (1,000 mg of ampicillin) and analgesic
agents (0.015 mg/kg of intramuscular buprenorfine). A tempo-
rary ventricular pacemaker (VVI) was sometimes placed after
the AV block operation and after the experiments. Pacing was
switched off after a maximum of 24 h.
Determination of almokalant dose. In dogs in sinus
rhythm, other investigators have shown (19) that 0.35 mg/kg of
almokalant had approximately two times the effect on repolar-
ization as 3 mg/kg of d-sotalol. In our previous studies (16–18)
we used 2 mg/kg d-sotalol to induce TdP by pacing. Because we
wanted to obtain a similar effect on action potential duration
(APD) prolongation, a dose of 0.12 mg/kg of almokalant (1/3
of 0.35 mg/kg 5 0.12) was chosen.
In the 14 dogs tested, d-sotalol was given first ([mean 6 SD]
4 6 2.2 weeks after creation of complete AV block) in 11 dogs,
followed by almokalant 3 6 2.1 weeks later. In three dogs the
order was reversed, with almokalant given at 5 6 2.6 weeks and
d-sotalol at 9 6 3.1 weeks of chronic complete AV block.
Induction of TdP arrhythmias. A detailed description of
the TdP protocol is described elsewhere (16). In short, at least
2 weeks after creation of complete AV block, anesthetized
animals received two defibrillation patches that were attached
to both sides of the chest and connected with a defibrillator. At
least 30 min after the onset of anesthesia, programmed elec-
trical stimulation was performed from the epicardial electrode.
Stimulation was done with a programmable stimulator capable
of pacing synchronously to the QRS complexes. Unipolar
stimuli were given using a pulse of 2 ms and a stimulus strength
of twice diastolic threshold. As an indifferent electrode, a
needle was placed through the skin.
Programmed electrical stimulation consisted of two differ-
ent pacing protocols: 1) a short–long–short sequence (400
800 1 extrastimulus, or 4p600 1,200 1 extrastimulus), and 2)
eight basic stimuli followed by an extrastimulus. The inter-
stimulus intervals were 600 or 1200 ms. The extrastimulus
interval in both pacing protocols was shortened from 500 ms
using steps of 50 ms until 300 ms. After completion of the basic
pacing protocol, d-sotalol (2 mg/kg for 5 min) or almokalant
(0.12 mg/kg for 10 min) was administered.
Pacing was resumed 10 min after the start of the infusion,
unless spontaneous TdP had occurred during the observation
period. When TdP occurred, we tried to perform the pacing
protocol at 15 min. Pacing was always performed in random
order. A TdP arrhythmia was defined as a polymorphic ventric-
ular tachycardia consisting of $5 beats twisting around the
baseline in the setting of a prolonged QT(U) duration. TdP
was terminated using cardioversion (60 to 70 J) when it lasted
.10 s. A dog was said to have inducible TdP when TdP was
induced three times or more using the same pacing mode or
when spontaneous initiation of TdP occurred (three times or
more). In one experiment, problems with cardioversion urged
us to stop prematurely, so that reproducibility could not be
assessed.
MAPs. MAPs were recorded to observe the occurrence of
EADs and to measure the duration of the action potential of
the left and right ventricles. Quadripolar contact electrodes
Abbreviations and Acronyms
APD 5 action potential duration
AV 5 atrioventricular
EADs 5 early afterdepolarizations
EBs 5 ectopic beats
LV 5 left ventricular
MAP 5 monophasic action potential
RV 5 right ventricular
TdP 5 torsade de pointes
DAPD 5 interventricular dispersion
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(Franz combination catheter, EPT No. 1650) that provide both
pacing and MAP recording capabilities were placed endocar-
dially in the right and left ventricles through the external
jugular vein and the carotid artery under fluoroscopic guid-
ance. MAP phases were defined according to the definitions
used for transmembrane potentials (20). Amplitude was de-
fined between phases 4 and 2 of the signal. Besides a minimal
amplitude of 15 mV, the MAP had to have a constant
configuration and a smooth shape during control circum-
stances. The MAP catheters were randomly placed in the
ventricle and accepted for analysis if all these conditions were
fulfilled. MAPs of good quality in both ventricles were present
in 11 of 14 experiments with almokalant and in 12 of 14
experiments with d-sotalol. EADs were defined as an interrup-
tion of the smooth contour of phase 2 or 3 of the action
potential (10). The presence of EADs was examined in both
MAPs.
Data analysis. With the use of a custom-made computer
program with a resolution of 2 ms and adjustable gain and time
scale, the following variables were measured every 30 s during
the first 10 to 15 min after the start of the class III medication:
cycle length of the idioventricular rhythm, QT time and APD.
In case EBs occurred, measurements were made solely in
single beats. Electrophysiologic data in the text and tables are
the mean of 5 consecutive (single) beats. In the graphs the
individual values are reported. All values were verified by an
independent observer (A.K.) in blinded manner. Interventricu-
lar dispersion (DAPD) was defined as the difference between
the left and right APD measured after total repolarization
(APD100). Also, the number of spontaneous EBs after both
drugs during this period were scored as single and multiple
EBs (i.e., doublets, triplets or quadruplets).
Statistics. Multiple measures analysis of variance, followed
by a Bonferroni t test, was used to compare the data between
the two treatments, and a chi-square test was used for data as
percentages. A p value #0.05 was considered significant.
Results are presented as mean value 6 SD. Furthermore, a
regression analysis was performed to calculate the correlation
between QT time and the other repolarization variables (left
and right ventricular APDs and DAPD).
Results
Baseline conditions were similar in each of the 14 serially
tested animals (Table 1).
Electrophysiologic and proarrhythmic effects of d-sotalol.
Values for cycle length, QT duration, APD of both ventricles
and DAPD are summarized in Table 1. At 10 min, d-sotalol
had significantly prolonged cycle length by 16% and QT
duration by 26% and also significantly increased the APD of
both the left and right ventricles. Because prolongation of the
action potential of the left ventricle was more pronounced
(27% vs. 21%), DAPD increased significantly (Table 1).
In the first 10 min, EADs were seen in 11 of 24 MAPs after
d-sotalol, which tended to appear more frequently in the left
than in the right ventricle (p , 0.1) (Table 2). Single EBs
developed in ,50% of the dogs (Table 2), with a maximum of
5 during 10 min (range 0 to 5). No dog developed spontaneous
TdP after d-sotalol.
The time-dependent electrophysiologic effects (0 to 10 min)
for left and right ventricular APDs are illustrated for a specific
dog in Figure 1. It can be clearly seen that the left ventricular
APD increased more than the right ventricular APD, leading
to a maximum DAPD of 150 ms at 8 min. In this dog, no EBs
occurred during this period, so there are no dynamic changes
in the APD.
Electrophysiologic and proarrhythmic effects of al-
mokalant. Almokalant also significantly increased the cycle
length and all repolarization variables. DAPD again increased
(p # 0.05) as a result of a more pronounced increase in the
APD of the left than in the right ventricle (45% vs. 29%)
(Table 1, Fig. 2 to 4). In the first 10 min, almokalant admin-
istration resulted in the occurrence of EADs in 18 of 22 MAPs
(Table 2) that occurred in both ventricles and contributed to
DAPD. Single EBs developed in almost all dogs with al-
mokalant. The maximal number was 109 single EBs/10 min
(mean 24 6 32). Moreover, multiple EBs were observed
(Table 2), with a maximum of 13 doublets (4.2 6 3.9), 8 triplets
(2.3 6 2.7) and 2 quadruplets (0.4 6 0.7). In some experiments
these spontaneous beats could be associated with triggering of
EADs recorded with the MAP catheter (Fig. 4).
In the first 10 min, almokalant induced repetitive sponta-
Table 1. Electrophysiologic Effects of d-Sotalol and Almokalant
d-Sotalol Almokalant
Baseline
(ms)
10 min
(ms)
%
Inc
Baseline
(ms)
10 min
(ms)
%
Inc
CL IVR 1,620 6 300 1,880 6 370* 116 1,670 6 360 1,910 6 425* 115
QT 390 6 50 495 6 80* 126 415 6 35 545 6 115* 131
LV APD 370 6 45 470 6 60* 127 375 6 45 545 6 95*† 145†
RV APD 320 6 30 390 6 45 121 335 6 35 435 6 60*† 129†
DAPD 50 6 25 80 6 45* 175 40 6 20 110 6 60*† 1330
*p , 0.05, 10 min versus baseline. †p , 0.05, almokalant versus d-sotalol. Data presented are mean value 6 SD.
APD 5 action potential duration; CL IVR 5 cycle length of idioventricular rhythm; Inc 5 increase; LV 5 left ventricular;
RV 5 right ventricular; DAPD 5 LV APD 2 RV APD.
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neous TdP in nine dogs (10 6 15 periods) (Fig. 4 and 5). The
time-dependent electrophysiologic effect of almokalant (0 to
8 min) is illustrated in Figure 2. In this dog, almokalant
induced single EBs at 200 s (Fig. 3), multiple EBs at 280 s and
spontaneous TdP at 6 min (Fig. 4). The occurrence of EBs was
associated with dynamic changes leading to additional in-
creases in the amount of DAPD due to the changes in LV APD
in the post-extrasystolic beat (Fig. 3). Before TdP, DAPD was
;200 ms (Fig. 2 and 4).
Compared with the animals given almokalant that did not
develop spontaneous TdP, the occurrence of TdP was associ-
ated with 1) a significantly larger DAPD (140 6 55 vs. 75 6
40 ms, p # 0.05) and LV APD, and 2) the presence of multiple
EBs (Table 2). No significant difference in the number of single
EBs was observed between the two groups (19 6 10 vs. 30 6 50
EBs).
Regression analysis between QT duration and other repo-
larization variables. The measured repolarization with the
MAP catheters showed good correlation with the QT duration
(Table 3) (LV APD: y 5 0.83x 1 51; RV APD: y 5 0.55x 1
109). There was also a positive although weak correlation
between DAPD and QT duration (y 5 0.27x 2 58, r2 5 0.32).
However, when the separate conditions were taken into con-
sideration (i.e., baseline vs. class III), the correlation between
QT and DAPD is absent, whereas the correlation between QT
and LV and RV APD remained present (Table 3).
Comparison of d-sotalol and almokalant. When d-sotalol
and almokalant were compared, no differences were found in
the amount of prolongation of the cycle length. However, the
effect on the repolarization variables was greater after al-
mokalant, including DAPD (Table 1). The number of EADs
and single EBs was also higher after almokalant (1.5 6 2 vs.
24 6 32 beats/10 min, p # 0.01). In addition, multiple EBs
were only seen after almokalant (Table 2). These EBs inter-
fered with the idioventricular rhythm, leading to APD adapta-
tions. The fact that this APD adaptation was most pronounced
in the left ventricle led to further increases in the DAPD and to
the occurrence of spontaneous TdP.
Induction of TdP after programmed electrical stimulation.
After d-sotalol, programmed electrical stimulation resulted in
the induction of TdP in five dogs. Programmed electrical
stimulation could not be performed in four of nine dogs with
spontaneously inducible TdP almokalant because ectopic ac-
tivity and periods of TdP prohibited this (Fig. 5, Table 2).
Table 2. Incidence of Early Afterdepolarizations and Torsade de Pointes Arrhythmias After
Administration of d-Sotalol and Almokalant
Dog
No. LV/RV
EADs EBs Indu of TdP
dS A dS A dS A
1 LV 1 1 None Single No No
RV 1 1
2 LV 1 1 Single Multiple PES Spon*
RV 2 1
3 LV 1 1 None Multiple No Spon
RV 2 1 1PES
4 LV 2 1 Single Multiple PES PES
RV 2 1
5 LV 2 1 None Multiple No Spon*
RV 2 1
6 LV 1 1 None Multiple PES Spon
RV 1 2 1PES
7 LV 1 1 None Multiple PES Spon*
RV 2 1
8 LV 1 1 None Multiple No Spon
RV 2 1 1PES
9 LV 1 2 Single Single PES PES
RV 2 2
10 LV 1 1 Single Multiple No Spon
RV 1 2 1PES
11 LV 2 1 None Multiple No PES
RV 2 1
12 LV 2 ND None Multiple No Spon
RV 2
13 ND Single Multiple No Spon*
14 ND None None No No
Total 11/24 18/22† 5/14 13/14 5/14 12/14†
*Because of continuous spontaneous (Spon) activity, no programmed electrical stimulation (PES) could be
performed. †p , 0.05 versus d-sotalol (dS). A 5 almokalant; EADs 5 early afterdepolarizations; EBs 5 ectopic beats
(multiple 5 2 to 4 ectopic beats); Indu 5 inducibility; LV 5 left ventricle; ND 5 not determined; RV 5 right ventricle;
TdP 5 torsade de pointes.
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Pacing induced TdP in four of the other five dogs (Table 2). Of
the five dogs without spontaneous arrhythmias, pacing resulted
in TdP in three. Therefore, a total of 12 of 14 dogs (9 sponta-
neous, 3 after pacing) developed TdP after almokalant.
A representative illustration of the difference in response to
d-sotalol and almokalant in the same dog is shown in Figure 6
(the same dog as in Fig. 1). After d-sotalol, DAPD is 90 ms
before pacing (Fig. 1 and 6). The APDs are smooth, and no
ectopic activity or TdP can be induced. After almokalant, this
dog demonstrated an DAPD of 115 ms, with EADs in both
ventricles. Pacing now resulted in the induction of a spontane-
ously terminating TdP. Dogs with inducible TdP by pacing had
a higher DAPD (120 6 55 vs. 75 6 30 ms, p # 0.05) than dogs
with noninducible TdP.
Figure 1. Time-dependent behav-
ior of LV and RV APD during and
after administration of d-sotalol.
LV and RV APD is depicted (y-
axis) just before and up to 20 min
after the start of d-sotalol (x-axis).
d-Sotalol increases the LV and RV
APD with different sensitivity: The
increase is more pronounced for
the LV APD, leading to an in-
crease in DAPD from 75 ms
(0 min) to 150 ms at 8 min. During
the observation period of 10 min,
EADs were observed in the left
ventricle; however no EBs devel-
oped, nor did a spontaneous TdP
arrhythmia arise. Therefore, no dy-
namic changes in APD length oc-
cur, and the curves of both APDs
are smooth. Programmed electrical
stimulation is performed starting at
20 min after the start of d-sotalol.
The APD of both ventricles is de-
creased, leading to a DAPD of ;60
to 90 ms. Pacing does not lead to
the induction of TdP (see Fig. 6).
Figure 2. Time-dependent (dynamic) behav-
ior of LV and RV APD during and after
administration of almokalant. Format as in
Figure 1. Under control condition 1 (see also
Panel 1, Fig. 3), the LV APD is longer than
the RV APD, leading to a DAPD of 35 to
45 ms. Directly after the start of almokalant,
the LV and RV APD start to increase. This
increase is not synchronous: The LV APD
increase is more pronounced, leading to a
more pronounced DAPD. By ;3 min (con-
dition 2 [see also right panel, Fig. 3]), single
EBs develop that are preceded by the occur-
rence of EADs in the left ventricle (see also
right panel, Fig. 3). These EBs lead to vari-
ations in the LV APD and to a more pro-
nounced DAPD. By ;4.5 min after the start
of almokalant, multiple EBs (mEBs) de-
velop, resulting in a DAPD of 160 ms. Just
before the spontaneous TdP arrhythmia
(condition 3 [see also Fig. 4]), the DAPD has
reached a value of 200 ms because of the
dynamic reaction of the LV APD to the
multiple EBs. Each acceleration in rate by
the EBs is followed by a transient decrease,
especially in the LV APD, leading to a
shorter DAPD and a temporary inability of
TdP to occur.
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Sequence of drug administration. When d-sotalol was
compared with almokalant, all dogs with inducible TdP during
d-sotalol also had inducible TdP with almokalant (Table 2).
These observations were independent of the sequence of
experiments. In two dogs, d-sotalol was administered in a third
experiment. The response was similar to that in the first
experiment, thereby confirming reproducibility.
Discussion
The exact contribution of the different factors leading to the
initiation of TdP is still a matter of discussion. Besides the
accepted variables, bradycardia and (class III induced) pro-
longed QT time, EADs and dispersion of repolarization have
been indicated. By using MAP catheters, the in vivo appear-
ance of EADs has been associated with EAD-triggered EBs
and a changed or more marked configuration of the T or TU
waves (21). Similarly, an increased intraventricular dispersion
has been found in patients with congenital or acquired TdP
(12). However, only one case report has shown a causal
relation between the occurrence of EAD-triggered EBs and
DAPD of repolarization to initiate spontaneous acquired TdP
(15). In the present study we tried to elucidate the relevance of
both variables and acquired spontaneous and pacing-induced
Figure 3. Occurrence of EADs and
single EBs after almokalant (0.12 mg/
kg for 10 min). Three electrocardio-
graphic leads (I, II and aVR) and two
MAPs (left and right ventricles) are
illustrated at a paper speed of 25
mm/s. These tracings are from data
from the same dog as in Figure 2.
Baseline conditions are shown in Panel
1. The action potentials are smooth,
and DAPD is 35 ms. Three minutes
after the start of almokalant (Panel 2),
the QT interval and APDs are in-
creased. An EAD is visible in the LV
MAP (arrow), and the DAPD has in-
creased to 95 ms. EBs arise, leading to
variations in the LV APD, from 435 to
505 ms. Because the RV APD in this
dog does not show similar changes,
DAPD varies accordingly from 85 to
140 ms.
Figure 4. Short-lasting spontaneous
TdP arrhythmia after almokalant.
Same dog as in Figure 3. Six min-
utes after almokalant, more EADs
have developed (arrow) that now
clearly trigger multiple EBs (aster-
isk). The DAPD has increased to
200 ms. This sequence of events
leads to a spontaneous, short-lasting
TdP arrhythmia.
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TdP by comparing the proarrhythmic effects of almokalant
with d-sotalol.
Factors contributing to interventricular dispersion. In a
recent paper (17), we demonstrated that DAPD is bradycardia
dependent. Both d-sotalol and almokalant prolong the cycle
length of the idioventricular rhythm equally. Almokalant in-
creased the different repolarization variables to a greater
extent than d-sotalol. In addition, EADs occurred more fre-
quently after almokalant, contributing to DAPD. Furthermore,
we indicated that the appearance of especially multiple EBs
leads to further prolongation of the DAPD. This abnormal rate
adaptation is especially observed in the LV APD and is present
in the post-extrasystolic beat after temporary increases in rate.
Longer periods of a increased rate show a normal rate
adaptation (i.e., shortening of the APD).
QT duration can be best predicted on the basis of the LV
APD. Because the LV APD determines DAPD, the latter
variable is also correlated with QT duration, although the
regression coefficient is much lower (Table 3). By concentrat-
ing on the specific circumstances (baseline or class III), we put
less emphasis on bradycardia and demonstrated the lack of
correlation between DAPD and QT duration, indicating that
DAPD is an independent factor.
Similar findings were observed with MgSO4 in a previous
report (17), where MgSO4 administration after d-sotalol re-
turned the DAPD to baseline, but the other repolarization
variables (QT duration and both APDs) where still signifi-
cantly prolonged (17).
Factors associated with spontaneous TdP. In order of
appearance, spontaneous occurrence of TdP after almokalant
(Fig. 2 to 4) was preceded by 1) an inhomogeneous increase in
left and right ventricular APD, 2) the occurrence of (sub-
threshold) EADs, 3) the occurrence of single followed by
multiple EBs, and 4) a further increase in DAPD resulting
from the dynamic response of the left ventricular APD because
of frequency changes. Spontaneous TdP was associated with
the appearance of multiple EBs and with a large DAPD. The
EBs seemed to be generated by the EADs, as clearly shown in
Figure 4 and indicated by the fact that they always appeared
after the occurrence of EADs.
It should be mentioned that in the experiments with
almokalant, electrophysiologic measurements were often ham-
pered by the recurrent presence of EBs and episodes of TdP.
This recurrence will lead to an underestimation of the electro-
physiologic effects of almokalant.
Factors associated with pacing-induced TdP. When spon-
taneous episodes of TdP occur, pacing will normally also lead
to the reproducible induction of these arrhythmias (Table 2)
(16). As shown in a previous study (17) and confirmed in the
Figure 5. Repetitive ectopic activity and TdP
after almokalant. Recordings are shown at a
paper speed of 10 mm/s. Before administra-
tion of almokalant (CONTROL), a stable
cycle length (1,510 ms) with a QT duration of
430 ms is present. Administration of al-
mokalant (0.12 mg/kg for 10 min) led to the
occurrence of EBs at 3 min. From that time to
30 min after the start of the infusion, episodes
of multiple EBs and TdP alternated with the
normal idioventricular rhythm. In this figure a
continuous recording of 225 s starting 5 min
after start of almokalant is shown. Almokalant
has increased the cycle length to 1,745 ms and
the QT duration to 680 ms. Furthermore, the
T wave has become more negative. At the end
of this T wave, an EB starts a period of TdP.
After cessation, another period of TdP
evolves. After a change in the site of origin of
the idioventricular rhythm (different QRS
configurations), a new episode of TdP now
starts after a short–long–short sequence.
Table 3. Regression Analysis of QT Duration and Other
Repolarization Variables
All Values
(n 5 42)
Baseline
(n 5 21)
Class III Agent
(n 5 21)
r2 p Value r2 p Value r2 p Value
LV APD 0.7 , 0.01 0.64 , 0.01 0.47 , 0.01
RV APD 0.62 , 0.01 0.58 , 0.01 0.34 , 0.01
DAPD 0.33 , 0.01 0.15 NS 0.12 NS
Abbreviations as in Table 1.
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present study, the main difference between dogs with pacing-
inducible and noninducible TdP is DAPD. Prevention or
suppression, or both, of pacing-induced TdP resulted from the
disappearance of EADs (13,16) and diminishment of DAPD
(17) by MgSO4.
The finding that the presence of single EBs does not differ
between dogs with pacing inducible and noninducible TdP
indicates that these beats occur during insufficient DAPD or
that the frequency changes induced by these beats do not lead
to a marked variation in APD (DAPD). That pacing is capable
of inducing TdP is possibly related to the coupling interval of
the paced beats or the generation of multiple beats. Until now
we have not been able to determine the dynamic changes
within the pacing train or the relevance of the pacing site for
the induction of TdP.
Possible causes of interventricular dispersion. In dogs
with chronic complete AV block, DAPD is present under
baseline conditions and shows bradycardia dependence: De-
creasing heart rate will increase DAPD (17). By their effect on
heart rate, class III agents will thus increase the interventric-
ular differences in APD.
In vitro studies (21) using isolated canine myocytes showed
that under baseline conditions, the APD of the left endocardial
(and epicardial) cells is longer than that of the right ventricle,
thereby creating DAPD. This difference has been described
(21) as even more pronounced for the M cell, located within
the myocardium.
Like the Purkinje fiber, the M cell has greater sensitivity for
class III agents in its ability to prolong the APD and to develop
EADs (21). The increase in DAPD in our experiments after
class III drugs is primarily due to a larger increase in the APD
of the left ventricle. The effect of almokalant (or d-sotalol)
could be different for the various tissues involved in the heart,
thus explaining the DAPD.
The M cells are not only present in dogs (21); recent studies
(22) also report the existence of these M cells in normal human
myocardium. It is not known to what extent the M cells
contribute to the APD, as recorded by the endocardially placed
MAP catheter.
Regional appearances of EADs can also explain the in-
crease in DAPD. d-Sotalol predominantly induced EADs in
the left ventricle, whereas almokalant produced EADs in both
ventricles. Because administration of almokalant led to a more
pronounced increase in DAPD than administration of d-
sotalol, the relative contribution of the amplitude of the EADs
might also be important.
Almokalant and d-sotalol: proarrhythmic and electrophysi-
ologic effects. The proarrhythmic potential of class III agents
is well known (1–9). Prolongation of repolarization is the
mechanism of the antiarrhythmic effect of class III drugs, but
prolongation is also associated with the risk of development of
TdP. Measurement of the absolute QT interval does not
Figure 6. Effect of programmed electrical stimulation on inducibility
of TdP after d-sotalol and almokalant in the same dog. Three
simultaneously recorded surface electrocardiographic leads and two
endocardial MAPs are presented. Paper speed is 10 mm/s. This figure
shows the effect of programmed electrical stimulation after d-sotalol
(Panel 1) and after almokalant (Panel 2) in the same dog as in Figure
1. After d-sotalol with a DAPD of 90 ms, programmed electrical
stimulation results in TdP. In contrast, almokalant induction of TdP is
observed after programmed electrical stimulation with a prepacing
DAPD of 115 ms.
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predict proarrhythmic potential in clinical conditions (5), as
shown in our animal model (23). Currently, QT dispersion (as
a variable of nonhomogenous repolarization) is frequently
mentioned (24) as a possible tool for predicting proarrhythmic
risk as well as antiarrhythmic efficacy. The QT dispersion
measured in multiple ECG leads correlates with the dispersion
in regional repolarization measured by epicardial MAPs (25).
Because QT dispersion shows large variation due to different
methodologies and different patient characteristics, the ques-
tion of its use as a general arrhythmic marker has yet to be
resolved (26).
It is thus important to screen new class III agents for their
proarrhythmic potential in an animal model. Most animal TdP
models have used nonclinically relevant drugs such as cesium
(10,13,27) or Bay K8644 (28). The only exceptions are an
awake AV block dog model with hypokalemia and beta-
blockade followed by antiarrhythmic drugs (29) and a rabbit
model (30). In the awake dog it is not yet possible to measure
MAPs and thereby correlate proarrhythmic findings with
EADs and APD. In the rabbit, TdP develops at relatively fast
heart rates after administration of class III agents and concom-
itant alpha-adrenergic stimulation. To our knowledge, compar-
ison between different agents in the same animal concomitant
with MAP recordings have not been described until the
present study (29–31).
Because the response of the dog is maintained over weeks,
serial comparison for screening of proarrhythmic effects of
(antiarrhythmic) drugs is feasible. Although this information
cannot be translated into the exact incidence of TdP in the
patient population, it allows an estimation of the relative risk
of drugs and their risk/benefit ratio.
Almokalant and d-sotalol both prolong the APD by block-
ade of K1 currents (32–34). Although almokalant is a selective
blocker of the rapid component of the delayed rectifier current
(IKr) (32,34), the published data are not consistent for d-
sotalol, which might also affect other K1 channels, such as the
inward rectifier current (IK1), the slow component of the
delayed rectifier current (IKs) and transient outward current
(Ito) (34–36). In addition, d-sotalol has some beta-blocking
effects (,5% of dl-sotalol [6]), whereas almokalant is devoid of
beta-blocking activity (33).
Limitations and implications. In the present study we
randomly placed two MAP catheters, one in the left and the
other in the right ventricle, to provide local information about
the differences in repolarization between the two ventricles
(DAPD). Possible transmual or intraventricular differences in
APD were not assessed in this study. Placement of multiple
catheters with d-sotalol revealed that the intraventricular
difference amounted only to 20% to 30% of the DAPD (17).
We do not know the type and number of cells contributing to
the MAP. Similarly, whether the presence of EADs on the
MAP is real or based on differences in transmural repolariza-
tion is not known (37). However, interventions specifically
directed to suppression of EAD formation, such as pacing and
drugs, leads to the disappearance of these EADs (16,17).
Transmural differences have been implicated in the mecha-
nism of TdP (21,38). In addition to their relevance for the
occurrence of EADs, differences in APD have been shown (39)
to create the substrate for a reentrant tachycardia. Whether
reentry plays a role in the initiation and continuation of TdP is
still unclear. It is conceivable that reentry succeeds or alter-
nates with triggered activity (38,40), or both, and is certainly
the case when TdP progresses to ventricular fibrillation.
DAPD is not likely to play a role in reentrant arrhythmias
because spatial dispersion is located so far apart. Still the
polymorphic appearance of TdP can be explained by DAPD.
The appearance of EBs from a single foci can lead to TdP
when this “monomorphic tachycardia” encounters continu-
ously shifting areas of repolarization. The situation becomes
more complicated when triggered EBs arise from multiple sites
in the ventricles.
Conclusions. Spontaneous TdP is associated with prolon-
gation of repolarization, the occurrence of EADs, the appear-
ance of (multiple) EBs and DAPD. The first three factors all
contribute to a further increase in DAPD. These findings also
show that the present canine model of TdP can be used to
screen new class III agents for their proarrhythmic potential.
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